Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Without offering a citation for a published paper or sharing any data, Sikirics 2025 review states that this clinical trial found that the drug was safe and well-tolerated in humans
Ragozzino G et al
GLP-1 medications are typically recommended for adults who meet specific Body Mass Index (BMI) criteria: Individuals with a BMI of 30 kg/m or greater (classified as obesity)
Nearly all PCOS patients prescribed semaglutide or tirzepatide also had obesity or type 2 diabetes, suggesting use remains primarily tied to metabolic indications, though broader interest in PCOS benefits is growing within scientific literature
If there's almost no human evidence why did the World Anti-Doping Agency ban it
US$ 26.14
US$ 22.01
US$ 22.78
US$ 20.09
US$ 20.30
US$ 20.07
